Qinglian Tang

1.3k total citations
44 papers, 932 citations indexed

About

Qinglian Tang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Qinglian Tang has authored 44 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 16 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Qinglian Tang's work include Sarcoma Diagnosis and Treatment (18 papers), Cancer-related molecular mechanisms research (5 papers) and Management of metastatic bone disease (5 papers). Qinglian Tang is often cited by papers focused on Sarcoma Diagnosis and Treatment (18 papers), Cancer-related molecular mechanisms research (5 papers) and Management of metastatic bone disease (5 papers). Qinglian Tang collaborates with scholars based in China, Canada and United States. Qinglian Tang's co-authors include Jinchang Lu, Guohui Song, Jingnan Shen, Huaiyuan Xu, Xianbiao Xie, Junqiang Yin, Changye Zou, Xiaojun Zhu, Zhiqiang Zhao and Jin Wang and has published in prestigious journals such as Journal of Clinical Investigation, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Qinglian Tang

35 papers receiving 925 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qinglian Tang China 19 505 342 249 200 172 44 932
Jinchang Lu China 16 488 1.0× 341 1.0× 216 0.9× 191 1.0× 150 0.9× 45 880
Xinhan Zhao China 14 402 0.8× 211 0.6× 351 1.4× 95 0.5× 152 0.9× 26 861
Jinghan Zhu China 16 511 1.0× 353 1.0× 153 0.6× 271 1.4× 211 1.2× 29 941
Sailan Zou China 9 561 1.1× 259 0.8× 348 1.4× 105 0.5× 226 1.3× 11 1.0k
Dengbo Ji China 16 498 1.0× 366 1.1× 328 1.3× 85 0.4× 130 0.8× 30 916
Gang Shi China 16 433 0.9× 275 0.8× 162 0.7× 74 0.4× 245 1.4× 43 816
Zhouyu Ning China 19 500 1.0× 357 1.0× 364 1.5× 134 0.7× 87 0.5× 40 911
Xinzheng Dai China 18 407 0.8× 196 0.6× 196 0.8× 144 0.7× 126 0.7× 29 877
Zhifei Lin China 14 660 1.3× 405 1.2× 313 1.3× 220 1.1× 413 2.4× 22 1.3k

Countries citing papers authored by Qinglian Tang

Since Specialization
Citations

This map shows the geographic impact of Qinglian Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinglian Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinglian Tang more than expected).

Fields of papers citing papers by Qinglian Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinglian Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinglian Tang. The network helps show where Qinglian Tang may publish in the future.

Co-authorship network of co-authors of Qinglian Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Qinglian Tang. A scholar is included among the top collaborators of Qinglian Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinglian Tang. Qinglian Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Guohui, Qinglian Tang, Jinchang Lu, et al.. (2025). Lenvatinib Monotherapy Versus Lenvatinib in Combination with PD-1 Blockades as Re-Challenging Treatment for Patients with Metastatic Osteosarcoma: A Real-World Study. Drug Design Development and Therapy. Volume 19. 1119–1128. 2 indexed citations
2.
Luo, Tianqi, et al.. (2025). Clinical Outcomes of Different Surgical Methods for Campanacci Grade III and Recurrent Giant Cell Tumors of the Distal Radius. Journal of the American Academy of Orthopaedic Surgeons. 34(1). e69–e80.
3.
Luo, Tianqi, Qinglian Tang, Chuangzhong Deng, et al.. (2025). Targeting OxLDL-mediated CD36 + CAF reprogramming potentiates PD-1 immunotherapy in osteosarcoma. Molecular Cancer. 25(1). 14–14.
4.
Yan, An, Anfei Huang, Qinglian Tang, et al.. (2024). Nickel–titanium alloy porous scaffolds based on a dominant cellular structure manufactured by laser powder bed fusion have satisfactory osteogenic efficacy. Materials Today Bio. 29. 101344–101344. 5 indexed citations
5.
Huang, Yufeng, Chuangzhong Deng, Anfei Huang, et al.. (2024). Mass Spectrometry–Based Proteomics Identifies Serpin B9 as a Key Protein in Promoting Bone Metastases in Lung Cancer. Molecular Cancer Research. 22(4). 402–414. 1 indexed citations
6.
Lin, Jiaming, Guohui Song, Anfei Huang, et al.. (2024). Design and validation of a novel 3D-printed glenohumeral fusion prosthesis for the reconstruction of proximal humerus bone defects: a biomechanical study. Frontiers in Bioengineering and Biotechnology. 12. 1428446–1428446. 1 indexed citations
7.
Zhou, Mi, Huaiyuan Xu, Qian Yang, et al.. (2024). NTRK-rearranged spindle cell tumor with SPECC1L-NTRK3 fusion in the thoracic spine: a case report. Journal of Cancer Research and Clinical Oncology. 151(1). 8–8.
8.
Huang, Yufeng, Qinglian Tang, Jinxin Hu, et al.. (2024). Development and validation of a novel immune-related prognostic model and the potential metastatic mechanism in synovial sarcoma. Frontiers in Immunology. 15. 1448464–1448464.
9.
Tang, Qinglian, Haidong Jia, Qin Xu, et al.. (2024). Scutellarein ameliorates dextran sulfate sodium-induced ulcerative colitis by inhibiting colonic epithelial cell proinflammation and barrier disruption. Frontiers in Pharmacology. 15. 1479441–1479441.
10.
Zhu, Xiaojun, Jiaming Lin, Guohui Song, et al.. (2024). 3D-printed modular prostheses for reconstruction of intercalary bone defects after joint-sparing limb salvage surgery for femoral diaphyseal tumours. Bone & Joint Open. 5(4). 317–323. 1 indexed citations
11.
Tang, Qinglian, Jinchang Lu, Xiaojun Zhu, et al.. (2023). The efficacy and safety of short-course neoadjuvant denosumab for en bloc spondylectomy in spinal giant cell tumor of bone: a preliminary report. European Spine Journal. 32(12). 4297–4305. 2 indexed citations
12.
Huang, Yufeng, Jiaming Lin, Anfei Huang, et al.. (2023). A nanodrug combining CD47 and sonodynamic therapy efficiently inhibits osteosarcoma deterioration. Journal of Controlled Release. 355. 68–84. 49 indexed citations
13.
Deng, Chuangzhong, Jianchang Fu, Xiaojun Zhu, et al.. (2020). Reprograming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma. Cancer Science. 111(6). 1899–1909. 67 indexed citations
14.
Zhu, Xiaojun, Jinchang Lu, Huaiyuan Xu, et al.. (2020). A Comparative Study Between Minimally Invasive Spine Surgery and Traditional Open Surgery for Patients With Spinal Metastasis. Spine. 46(1). 62–68. 27 indexed citations
15.
Shao, Yang, Geoffrey A. Wood, Jinchang Lu, et al.. (2018). Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcoma. Oncogene. 38(2). 291–298. 56 indexed citations
16.
17.
Lu, Jinchang, Guohui Song, Qinglian Tang, et al.. (2015). IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling. Journal of Clinical Investigation. 125(5). 1839–1856. 98 indexed citations
18.
Molyneux, Sam D., Paul Waterhouse, Dawne N. Shelton, et al.. (2014). Human somatic cell mutagenesis creates genetically tractable sarcomas. Nature Genetics. 46(9). 964–972. 23 indexed citations
19.
Zhao, Zhiqiang, Changye Zou, Qinglian Tang, et al.. (2013). Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-κB pathway. Cancer Letters. 342(1). 150–158. 94 indexed citations
20.
Tang, Qinglian, Xianbiao Xie, Junqiang Yin, et al.. (2011). Enrichment of osteosarcoma stem cells by chemotherapy. Chinese Journal of Cancer. 426–432. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinchang Lu Breakdown of academic impact, for papers by Xinhan Zhao Breakdown of academic impact, for papers by Jinghan Zhu Breakdown of academic impact, for papers by Sailan Zou Breakdown of academic impact, for papers by Dengbo Ji Breakdown of academic impact, for papers by Gang Shi Breakdown of academic impact, for papers by Zhouyu Ning Breakdown of academic impact, for papers by Xinzheng Dai Breakdown of academic impact, for papers by Zhifei Lin
Rankless by CCL
2026